Condition
PostCovid
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07821385CompletedPrimary
Interprofessional Rehabilitation for Patients With Post-COVID Condition
NCT07359482Phase 3RecruitingPrimary
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
NCT05238415Not ApplicableCompleted
ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19
NCT06897553Not ApplicableRecruiting
ACT for Mental Health in Neurological Disorders
Showing all 4 trials